Literature DB >> 23002979

Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach.

Nathaniel D Lambert1, Inna G Ovsyannikova, V Shane Pankratz, Robert M Jacobson, Gregory A Poland.   

Abstract

Annual vaccination against seasonal influenza is recommended to decrease disease-related mortality and morbidity. However, one population that responds suboptimally to influenza vaccine is adults over the age of 65 years. The natural aging process is associated with a complex deterioration of multiple components of the host immune system. Research into this phenomenon, known as immunosenescence, has shown that aging alters both the innate and adaptive branches of the immune system. The intricate mechanisms involved in immune response to influenza vaccine, and how these responses are altered with age, have led us to adopt a more encompassing systems biology approach to understand exactly why the response to vaccination diminishes with age. Here, the authors review what changes occur with immunosenescence, and some immunogenetic factors that influence response, and outline the systems biology approach to understand the immune response to seasonal influenza vaccination in older adults.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002979      PMCID: PMC3514506          DOI: 10.1586/erv.12.61

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  103 in total

1.  Developing the next generation of vaccinologists.

Authors:  Gregory A Poland; Myron M Levine; John D Clemens
Journal:  Vaccine       Date:  2010-12-06       Impact factor: 3.641

2.  Clinical and immunologic predictors of influenza illness among vaccinated older adults.

Authors:  Zainab Shahid; Alison Kleppinger; Beth Gentleman; Ann R Falsey; Janet E McElhaney
Journal:  Vaccine       Date:  2010-07-31       Impact factor: 3.641

3.  Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.

Authors:  Laura Denney; Celia Aitken; Chris Ka-Fai Li; Eleri Wilson-Davies; Wai Ling Kok; Colin Clelland; Kevin Rooney; Duncan Young; Tao Dong; Andrew J McMichael; William F Carman; Ling-Pei Ho
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

4.  Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly.

Authors:  Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

5.  Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.

Authors:  Kok-Fai Kong; Karine Delroux; Xiaomei Wang; Feng Qian; Alvaro Arjona; Stephen E Malawista; Erol Fikrig; Ruth R Montgomery
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 6.  Systems vaccinology.

Authors:  Bali Pulendran; Shuzhao Li; Helder I Nakaya
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

7.  Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.

Authors:  Anna H Roukens; Darius Soonawala; Simone A Joosten; Adriëtte W de Visser; Xiaohong Jiang; Kees Dirksen; Marjolein de Gruijter; Jaap T van Dissel; Peter J Bredenbeek; Leo G Visser
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

8.  TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.

Authors:  Beena Puthothu; Johannes Forster; Andrea Heinzmann; Marcus Krueger
Journal:  Dis Markers       Date:  2006       Impact factor: 3.434

Review 9.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

10.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  57 in total

Review 1.  Fast vaccine design and development based on correlates of protection (COPs).

Authors:  Cécile van Els; Siri Mjaaland; Lisbeth Næss; Julia Sarkadi; Eva Gonczol; Karen Smith Korsholm; Jon Hansen; Jørgen de Jonge; Gideon Kersten; Jennifer Warner; Amanda Semper; Corine Kruiswijk; Fredrik Oftung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Authors:  Nimalan Arinaminpathy; Inkyu Kevin Kim; Paul Gargiullo; Michael Haber; Ivo M Foppa; Manoj Gambhir; Joseph Bresee
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

3.  A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.

Authors:  Giovanni Della Cioppa; Uwe Nicolay; Kelly Lindert; Geert Leroux-Roels; Frédéric Clement; Flora Castellino; Cristina Galli; Nicola Groth; Yotam Levin; Giuseppe Del Giudice
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

Review 4.  Influenza vaccination in the elderly.

Authors:  Jan Smetana; Roman Chlibek; Jana Shaw; Miroslav Splino; Roman Prymula
Journal:  Hum Vaccin Immunother       Date:  2017-08-04       Impact factor: 3.452

Review 5.  Influenza vaccines: challenges and solutions.

Authors:  Katherine Houser; Kanta Subbarao
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

Review 6.  The immune system in menopause: pros and cons of hormone therapy.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-13       Impact factor: 4.292

7.  High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis.

Authors:  Dana C Miskulin; Daniel E Weiner; Hocine Tighiouart; Eduardo K Lacson; Klemens B Meyer; Taimur Dad; Harold J Manley
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-23       Impact factor: 8.237

Review 8.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

9.  Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals.

Authors:  Inna G Ovsyannikova; Sarah J White; Beth R Larrabee; Diane E Grill; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2013-12-18       Impact factor: 3.641

Review 10.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.